Delivery Order SPE2DB20D3103-SPE2DB23FP9D4
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $3,708.59 for the supply of Rosuvastatin Calcium 10 mg tablets. The contract has an ultimate completion date of December 18, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $17,373.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Rosuvastatin Calcium 5 mg tablets in quantities of 500 tablets, with a completion date of April 18, 2023. This is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $59,871.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,618,267 units of rosuvastatin calcium 40 mg tablets over a period ending on August 29, 2024. This is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation is for the delivery of 500 units of Rosuvastatin Calcium 5 mg tablets. The award has a ceiling value of $23,241.90 and a completion date of February 26, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The $5,421.05 firm fixed price contract is for the delivery of 4,564,603,768 units of Rosuvastatin Calcium 10 mg tablets by May 15, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD)...
- This federal contract award, identified as SPE2DB20D2014|SPE2DB24FA26F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,228.46 firm fixed-price delivery order is for the supply of 500 units of Rosuvastatin Calcium 40 mg tablets. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $26,023.34 firm fixed-price delivery order contract is for the supply of 4,564,414,347 units of Rosuvastatin Calcium 20 mg tablets. The contract has an ultimate completion date of April 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at...
- This federal contract award, with ID SPE2DX15D6044|SPE2DX24FCQUR, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp's Corporate Office Division. The $1,807.20 firm fixed price delivery order is for the provision of 4,564,288,624 units of Rosuvastatin Calcium 40 mg tablets. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,259.72, is a delivery order for the medication Crestor 40 mg tablet, with a completion date of February 24, 2025. The contract is a firm fixed-price arrangement with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $1,202.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Rosuvastatin Calcium 40 mg tablets, a cardiovascular medication. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with a ceiling value of $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc....
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP9D4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,508.30 delivery order contract is for the supply of Rosuvastatin Calcium 10 mg tablets. The contract has a firm fixed-price pricing type and an ultimate completion date of September 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is likely part of that larger IDC. The contract does not have any set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/27/23 |